4886

JP:CO:ASKA-PHARMA-HD

あすか製薬ホールディングス株式会社

  • Stock

Last Close

2,121.00

12/11 06:45

Market Cap

67.99B

Beta: -

Volume Today

56.90K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
revenue
39.50B
-
42.91B
8.62%
43.22B
0.72%
48.53B
12.29%
48.94B
0.86%
46.70B
4.57%
52.54B
12.50%
55.18B
5.02%
56.61B
2.58%
60.46B
6.81%
62.84B
3.94%
cost of revenue
22.43B
-
25.71B
14.64%
26.07B
1.39%
29.61B
13.59%
30.06B
1.50%
27.81B
7.47%
28.52B
2.56%
29.80B
4.46%
30.25B
1.53%
31.88B
5.36%
32.18B
0.95%
gross profit
17.07B
-
17.19B
0.72%
17.14B
0.28%
18.91B
10.32%
18.89B
0.15%
18.89B
0.03%
24.02B
27.13%
25.38B
5.69%
26.35B
3.82%
28.59B
8.47%
30.66B
7.28%
selling and marketing expenses
1.10B
-
1.05B
4.37%
1.02B
2.76%
1.01B
0.78%
963M
4.94%
885M
8.10%
5.99B
577.18%
5.77B
-
6.09B
5.57%
general and administrative expenses
11.11B
-
10.69B
3.77%
10.78B
0.85%
11.14B
3.27%
11.04B
0.84%
11.73B
6.22%
11.60B
1.07%
12.19B
-
13.16B
7.96%
selling general and administrative expenses
12.21B
-
11.74B
3.83%
11.80B
0.53%
12.15B
2.92%
12.01B
1.19%
12.61B
5.07%
17.60B
39.50%
21.77B
23.74%
17.96B
17.52%
19.25B
7.19%
19.44B
0.97%
research and development expenses
4.14B
-
4.03B
2.87%
4.17B
3.70%
4.97B
19.07%
4.05B
18.41%
4.49B
10.80%
4.91B
9.35%
3.60B
-
4.23B
17.48%
4.73B
11.85%
other expenses
-73M
-
-67M
8.22%
cost and expenses
6.16B
-
10.06B
63.40%
10.19B
1.30%
13.77B
35.15%
14.06B
2.11%
44.92B
219.45%
51.03B
13.61%
51.57B
1.05%
51.81B
0.47%
55.35B
6.83%
56.34B
1.79%
operating expenses
16.27B
-
15.65B
3.81%
15.88B
1.44%
15.84B
0.25%
16.00B
0.98%
17.11B
6.94%
22.51B
31.58%
21.77B
3.27%
21.56B
1.00%
23.48B
8.91%
24.16B
2.93%
interest expense
41M
-
64M
56.10%
59M
7.81%
56M
5.08%
50M
10.71%
40M
20%
ebitda
3.16B
-
3.23B
2.06%
3.22B
0.09%
4.29B
33.26%
5.22B
21.51%
4.40B
15.65%
5.27B
19.70%
6.97B
32.32%
7.86B
12.78%
8.46B
7.62%
9.16B
8.28%
operating income
702M
-
1.41B
101.00%
1.17B
17.36%
1.79B
53.86%
2.83B
57.47%
1.78B
36.85%
1.51B
15.47%
3.61B
139.39%
4.79B
32.83%
5.11B
6.53%
6.50B
27.27%
depreciation and amortization
2.46B
-
1.81B
26.19%
2.06B
13.33%
2.50B
21.58%
2.39B
4.28%
2.62B
9.36%
3.76B
43.66%
3.36B
10.61%
2.88B
14.19%
3.13B
8.39%
2.66B
14.87%
total other income expenses net
244M
-
277M
13.52%
281M
1.44%
1.51B
435.94%
237M
84.26%
99M
58.23%
-607M
713.13%
-35M
94.23%
1.37B
4,008.57%
247M
81.94%
3.36B
1,260.73%
income before tax
946M
-
1.69B
78.44%
1.45B
14.28%
3.30B
128.06%
3.06B
7.21%
1.88B
38.50%
901M
52.15%
3.58B
296.78%
6.16B
72.39%
5.36B
13.08%
9.86B
84.10%
income tax expense
421M
-
530M
25.89%
746M
40.75%
356M
52.28%
674M
89.33%
138M
79.53%
252M
82.61%
861M
241.67%
1.87B
117.54%
1.12B
40.31%
2.32B
107.16%
net income
495M
-
1.19B
141.01%
701M
41.24%
2.94B
319.97%
2.39B
18.89%
1.74B
26.97%
649M
62.79%
2.71B
318.03%
4.29B
58.13%
4.24B
1.21%
7.54B
78.03%
weighted average shs out
27.77M
-
27.83M
0.22%
27.89M
0.19%
27.94M
0.19%
28.17M
0.83%
28.22M
0.17%
28.29M
0.24%
28.37M
0.29%
28.37M
0.00%
28.24M
0.46%
28.31M
0.26%
weighted average shs out dil
27.77M
-
27.83M
0.22%
27.89M
0.19%
27.94M
0.19%
28.17M
0.83%
28.22M
0.17%
28.29M
0.24%
28.37M
0.29%
28.37M
0.00%
28.24M
0.46%
28.31M
0.26%
eps
17.82
-
42.86
140.52%
25.14
41.34%
105.37
319.13%
84.77
19.55%
61.80
27.10%
22.94
62.88%
95.63
316.87%
151.22
58.13%
150.08
0.75%
266.48
77.56%
epsdiluted
17.82
-
42.86
140.52%
25.14
41.34%
105.37
319.13%
84.77
19.55%
61.80
27.10%
22.94
62.88%
95.63
316.87%
151.22
58.13%
150.08
0.75%
266.48
77.56%

All numbers in (except ratios and percentages)